|
S5
|
Leveraging Genomic Diversity to Promote Animal and Human Health
|
|
|
|
Nov. 25–29, 2018
|
|
A1
|
DNA Replication and Genome Instability: From Mechanism to Disease
|
|
|
|
Jan. 13–17, 2019
|
|
A3
|
Tuberculosis: Mechanisms, Pathogenesis and Treatment
|
|
|
|
Jan. 17–21, 2019
|
|
A4
|
Integrated Pathways of Disease in NASH and NAFLD
|
|
|
|
Jan. 20–24, 2019
|
|
L2
|
Cancer Vaccines
|
|
|
|
Jan. 20–24, 2019
|
|
A5
|
Digital Health: From Science to Application
|
|
|
|
Jan. 21–25, 2019
|
|
A6
|
Windows on the Brain: Formation and Function of Synapses and Circuits and their Disruption in Disease
|
|
|
|
Jan. 21–25, 2019
|
|
J3
|
Cellular Plasticity: Reprogramming, Regeneration and Metaplasia
|
|
|
|
Jan. 27–31, 2019
|
|
J4
|
Signal Dynamics and Signal Integration in Development and Disease
|
|
|
|
Jan. 27–31, 2019
|
|
B1
|
Transcription and RNA Regulation in Inflammation and Immunity
|
|
|
|
Feb. 2–5, 2019
|
|
J5
|
Molecular Approaches to Vaccines and Immune Monitoring
|
N/A
|
N/A
|
N/A
|
Feb. 10–14, 2019
|
|
J7
|
Obesity and Adipose Tissue Biology
|
N/A
|
N/A
|
N/A
|
Feb. 10–14, 2019
|
|
J8
|
Functional Neurocircuitry of Feeding and Feeding Disorders
|
N/A
|
N/A
|
N/A
|
Feb. 10–14, 2019
|
|
B2
|
Autophagy: From Model Systems to Therapeutic Opportunities
|
|
|
|
Feb. 17–21, 2019
|
|
B3
|
Uncovering Mechanisms of Immune-Based Therapy in Cancer and Autoimmunity
|
|
|
|
Feb. 18–22, 2019
|
|
B4
|
Genome Engineering: From Mechanisms to Therapies
|
|
|
|
Feb. 19–23, 2019
|
|
B5
|
Tumor Metabolism
|
|
|
|
Feb. 24–28, 2019
|
|
B7
|
Myeloid Cells
|
|
|
|
Feb. 24–28, 2019
|
|
X1
|
RNA-Protein Interactions
|
|
|
|
Feb. 24–28, 2019
|
|
X2
|
Long Noncoding RNAs: From Molecular Mechanism to Functional Genetics
|
|
|
|
Feb. 24–28, 2019
|
|
C1
|
Phenotypic Drug Discovery: Recent Advances and Insights from Chemical and Systems Biology
|
|
|
|
Mar. 3–7, 2019
|
|
X3
|
Diabetes: Innovations, Outcomes and Personalized Therapies
|
|
|
|
Mar. 3–7, 2019
|
|
X4
|
Unraveling the Secrets of Kidney Disease
|
|
|
|
Mar. 3–7, 2019
|
|
C3
|
Microbiome: Chemical Mechanisms and Biological Consequences
|
|
|
|
Mar. 10–14, 2019
|
|
M1
|
Innate Immune Receptors: Roles in Immunology and Beyond
|
N/A
|
N/A
|
N/A
|
Mar. 10–14, 2019
|
|
M2
|
Cancer Metastasis: The Role of Metabolism, Immunity and the Microenvironment
|
N/A
|
N/A
|
N/A
|
Mar. 15–19, 2019
|
|
X5
|
Epigenetics and Human Disease
|
N/A
|
N/A
|
N/A
|
Mar. 17–21, 2019
|
|
M3
|
Origins of Allergic Disease: Microbial, Epithelial and Immune Interactions
|
N/A
|
N/A
|
N/A
|
Mar. 24–27, 2019
|
|
C5
|
Innate and Non-Classical Immune Cells in Cancer Immunotherapy
|
N/A
|
N/A
|
N/A
|
Mar. 24–28, 2019
|
|
X7
|
HIV Vaccines
|
Oct 23, 2018
|
N/A
|
N/A
|
Mar. 24–28, 2019
|
|
X8
|
Functional Cures and the Eradication of HIV
|
Oct 23, 2018
|
N/A
|
N/A
|
Mar. 24–28, 2019
|
|
C6
|
Lipidomics and Functional Metabolic Pathways in Disease
|
N/A
|
N/A
|
N/A
|
Mar. 31–Apr. 4, 2019
|
|
L3
|
Protein Replacement through Nucleic Acid Therapies
|
N/A
|
N/A
|
N/A
|
Apr. 7–10, 2019
|
|
D2
|
Antibodies as Drugs: New Horizons in the Therapeutic Use of Engineered Antibodies
|
N/A
|
N/A
|
N/A
|
Apr. 7–11, 2019
|
|
D6
|
Immunometabolism, Metaflammation and Metabolic Disorders
|
N/A
|
N/A
|
N/A
|
Apr. 14–18, 2019
|
|
E1
|
Delivering Therapeutics Across Biological Barriers
|
N/A
|
N/A
|
N/A
|
May. 6–9, 2019
|
|
M4
|
Climate Change-Linked Stress Tolerance in Plants
|
Dec 18, 2018
|
N/A
|
N/A
|
May. 13–16, 2019
|
|
E2
|
Positive-Strand RNA Viruses
|
Jan 8, 2019
|
N/A
|
N/A
|
Jun. 9–13, 2019
|
|
Z1
|
Neural Environment in Disease: Glial Responses and Neuroinflammation
|
N/A
|
N/A
|
N/A
|
Jun. 16–20, 2019
|
|
Z2
|
Neurodegenerative Diseases: New Insights and Therapeutic Opportunities
|
N/A
|
N/A
|
N/A
|
Jun. 16–20, 2019
|
|
T1
|
Microbiome: Therapeutic Implications
|
N/A
|
N/A
|
N/A
|
Oct. 6–10, 2019
|
|
G1
|
The Malaria Endgame: Innovation in Therapeutics, Vector Control and Public Health Tools
|
Jun 11, 2019
|
N/A
|
N/A
|
Oct. 30–Nov. 2, 2019
|
|
T3
|
Why So Many Ways to Die? Apoptosis, Necroptosis, Pyroptosis and Beyond
|
Jul 16, 2019
|
N/A
|
N/A
|
Nov. 19–23, 2019
|
|
T4
|
Helminths: New Insights from Immunity to Global Health
|
Jul 9, 2019
|
N/A
|
N/A
|
Dec. 8–12, 2019
|
|
A1
|
Noncoding RNAs: Mechanism, Function and Therapies
|
N/A
|
N/A
|
N/A
|
Jan. 12–16, 2020
|
|
A2
|
Tuberculosis: Immunity and Immune Evasion
|
Aug 13, 2019
|
N/A
|
N/A
|
Jan. 16–20, 2020
|
|
A3
|
Hypoxia: Molecules, Mechanisms and Disease
|
N/A
|
N/A
|
N/A
|
Jan. 19–23, 2020
|
|
L1
|
Cancer Evolution and Combinatorial Cancer Therapies: Concepts and Challenges
|
N/A
|
N/A
|
N/A
|
Jan. 19–23, 2020
|
|
A5
|
AAA+ Proteins: From Atomic Structures to Organisms
|
N/A
|
N/A
|
N/A
|
Jan. 26–29, 2020
|
|
A6
|
Tissue Immunity
|
N/A
|
N/A
|
N/A
|
Jan. 26–29, 2020
|
|
J3
|
Gene Regulation: From Mechanisms to Disease
|
N/A
|
N/A
|
N/A
|
Jan. 26–30, 2020
|
|
B1
|
Antibodies as Drugs: From B Cell Biology to New Treatments
|
N/A
|
N/A
|
N/A
|
Feb. 2–6, 2020
|
|
Q1
|
Emerging Cellular Therapies: Cancer and Beyond
|
N/A
|
N/A
|
N/A
|
Feb. 8–12, 2020
|
|
Q2
|
Engineering the Genome
|
N/A
|
N/A
|
N/A
|
Feb. 8–12, 2020
|
|
B2
|
Intra- and Intercellular Mechanisms of Aging
|
N/A
|
N/A
|
N/A
|
Feb. 9–13, 2020
|
|
Q3
|
Brain Therapeutics: Disruptive Technologies and Opportunities
|
N/A
|
N/A
|
N/A
|
Feb. 16–19, 2020
|
|
Q4
|
Cerebral Fluid Flow and Function: Lymphatics, Glymphatics and the Choroid Plexus
|
N/A
|
N/A
|
N/A
|
Feb. 16–19, 2020
|
|
Q5
|
Stromal Cells in Immunity and Disease
|
N/A
|
N/A
|
N/A
|
Feb. 19–23, 2020
|
|
EK1
|
Advances in Cancer Immunotherapy
|
Aug 10, 2020
|
N/A
|
N/A
|
Aug. 17–19, 2020
|
|
EK5
|
RNA Editing and Modifications: From Biology to Therapy
|
Oct 2, 2020
|
N/A
|
N/A
|
Sep. 30–Oct. 2, 2020
|
|
EK21
|
Sleep & Circadian Rhythms: Pillars of Health
|
N/A
|
N/A
|
N/A
|
Feb. 25–25, 2021
|
|
X3
|
Innate Immune Memory: From Evolutionary Roots to Human Disease
|
|
|
|
Mar. 6–9, 2022
|
|
C1
|
Cancer Immunotherapy: Decoding the Cancer Immunity Interactome
|
|
|
|
Mar. 20–24, 2022
|
|
C2
|
Next Generation HIV Vaccines & Therapies
|
|
|
|
Mar. 27–30, 2022
|
|
D1
|
Innate Immunity: Complement and Beyond
|
|
|
|
Apr. 3–6, 2022
|
|
T4
|
B Cell-T Cell Collaboration: Regulation and Dysregulation
|
|
|
|
Apr. 3–6, 2022
|
|
E1
|
Small Regulatory RNAs: From Bench to Bedside
|
Apr 20, 2022
|
N/A
|
N/A
|
May. 1–4, 2022
|
|
T8
|
Progress in Vaccine Development for Infectious Diseases
|
|
|
|
Jun. 1–4, 2022
|
|
Z1
|
Neuro-Immune Interactions in the Central Nervous System
|
May 26, 2022
|
N/A
|
N/A
|
Jun. 5–9, 2022
|
|
RB1
|
Advances in Checkpoints Immunology from Autoimmunity to Oncology to Infectious Diseases (Rescheduled from February 2022)
|
N/A
|
N/A
|
N/A
|
Jun. 8–12, 2022
|
|
E3
|
Positive-Strand RNA Viruses
|
|
|
|
Jun. 18–22, 2022
|
|
RJ3
|
Viral Immunity: Basic Mechanisms and Therapeutic Applications (Rescheduled from January 2022)
|
|
|
|
Jun. 29–Jul. 2, 2022
|
|
RJ1
|
Immunometabolism at the Crossroads of Obesity and Cancer (Rescheduled from January 2022)
|
|
|
|
Sep. 5–8, 2022
|
|
TEMPLATE E
|
Template Event for Standard Session Proposals Configuration
|
|
|
|
Sep. 12–12, 2022
|
|
RB3
|
Exosomes, Microvesicles and Other Extracellular Vesicles (Rescheduled from February 2022)
|
|
|
|
Oct. 30–Nov. 2, 2022
|
|
RJ5
|
Ubiquitin Biology (Rescheduled from January 2022)
|
Jan 9, 2023
|
N/A
|
N/A
|
Nov. 6–9, 2022
|
|
RJ6
|
Targeted Protein Degradation - RESCHEDULED
|
N/A
|
N/A
|
N/A
|
Nov. 6–9, 2022
|
|
EK2
|
Reimagining Scientific Conferences
|
N/A
|
N/A
|
N/A
|
Nov. 15–16, 2022
|
|
EK1
|
Inborn Errors of Immunity: From Genetics to Basic Immunological Principles to Therapy
|
Nov 24, 2022
|
N/A
|
N/A
|
Dec. 5–7, 2022
|
|
RQ4
|
Novel Approaches Against Emerging Antimicrobial Resistance (Rescheduled from February 2022)
|
N/A
|
N/A
|
N/A
|
Dec. 4–7, 2022
|
|
RQ3
|
The Human Microbiome: Ecology and Evolution (Rescheduled from February 2022)
|
N/A
|
N/A
|
N/A
|
Dec. 4–7, 2022
|
|
T8
|
Influenza: From Correlates of Protection to Next Generation Vaccines
|
|
|
|
Jan. 1–4, 2023
|
|
Y3
|
Biomolecular Condensates: Phase-Separated Organizers of Cellular Biochemistry
|
|
|
|
Jan. 1–4, 2023
|
|
Y4
|
Neuronal Cell Biology: A Biology of Extremes
|
|
|
|
Jan. 1–4, 2023
|
|
J3
|
Adipose Tissue: Energizing Good Fat
|
N/A
|
N/A
|
N/A
|
Jan. 15–19, 2023
|
|
J4
|
Bioenergetics in Health and Diseases
|
N/A
|
N/A
|
N/A
|
Jan. 15–19, 2023
|
|
J6
|
Infections in Pregnancy: Pathogenic Mechanisms, Experimental Advances and Clinical Strategies
|
N/A
|
N/A
|
N/A
|
Jan. 22–25, 2023
|
|
J5
|
Maternal-Fetal Crosstalk: From Association to Mechanism
|
Oct 20, 2022
|
N/A
|
N/A
|
Jan. 22–25, 2023
|
|
A1
|
Drug Delivery to the Brain: Challenges and Progress
|
Mar 27, 2023
|
N/A
|
N/A
|
Jan. 23–26, 2023
|
|
J8
|
Protein-RNA Interactions
|
N/A
|
N/A
|
N/A
|
Jan. 29–Feb. 1, 2023
|
|
J7
|
Biomolecular Condensates: Emerging Cellular and Biophysical Roles
|
N/A
|
N/A
|
N/A
|
Jan. 29–Feb. 1, 2023
|
|
A4
|
Emerging Cellular Therapies at the Forefront of Cancer Immunotherapy
|
Apr 4, 2023
|
N/A
|
N/A
|
Jan. 29–Feb. 2, 2023
|
|
Q1
|
Stem Cells: Advances in the Application of Stem Cells and their Role in vivo
|
Apr 10, 2023
|
N/A
|
N/A
|
Feb. 5–8, 2023
|
|
Q2
|
Organoids as Models of Development and Disease, and their Impact on Drug Discovery
|
Apr 10, 2023
|
N/A
|
N/A
|
Feb. 5–8, 2023
|
|
B1
|
Heart Development and Disease: From Genes to Cures
|
N/A
|
N/A
|
N/A
|
Feb. 12–15, 2023
|
|
Q3
|
Skin-Immune Crosstalk
|
N/A
|
N/A
|
N/A
|
Feb. 13–16, 2023
|
|
Q4
|
Vector Biology: Emerging Concepts and Novel Technologies
|
N/A
|
N/A
|
N/A
|
Feb. 13–16, 2023
|
|
Q6
|
Multispecific Immune Cell Engagers for Cancer Immunotherapy
|
N/A
|
N/A
|
Apr 24, 2023
|
Feb. 19–22, 2023
|
|
Q5
|
Next Generation Antibody Therapeutics: From Discovery to Patient
|
N/A
|
N/A
|
Apr 24, 2023
|
Feb. 19–22, 2023
|
|
C2
|
Cancer Immunotherapy: Mechanisms of Response versus Resistance
|
N/A
|
N/A
|
May 9, 2023
|
Mar. 5–9, 2023
|
|
Q8
|
Chromatin Architecture in Development and Human Health
|
N/A
|
N/A
|
May 15, 2023
|
Mar. 12–15, 2023
|
|
Q7
|
Epigenetics, Chromatin, Development and Disease
|
N/A
|
N/A
|
May 15, 2023
|
Mar. 12–15, 2023
|
|
RJ8
|
Computational Design and Modeling of Biomolecules (Rescheduled from January 2022)
|
N/A
|
N/A
|
May 17, 2023
|
Mar. 14–17, 2023
|
|
X1
|
Genomic Instability and DNA Repair
|
N/A
|
N/A
|
May 23, 2023
|
Mar. 19–23, 2023
|
|
X3
|
Fibrosis Pathogenesis and Resolution: From Mechanisms to Therapies
|
N/A
|
N/A
|
May 23, 2023
|
Mar. 19–23, 2023
|
|
X4
|
Metabolic and Molecular Mechanisms of NAFLD/NASH
|
N/A
|
N/A
|
May 23, 2023
|
Mar. 19–23, 2023
|
|
X2
|
Precision Genome Engineering
|
N/A
|
N/A
|
May 23, 2023
|
Mar. 19–23, 2023
|
|
X5
|
Mitochondrial Dysfunction: From Ultra-Rare Diseases to Aging
|
N/A
|
N/A
|
May 29, 2023
|
Mar. 26–29, 2023
|
|
X6
|
Molecular Basis of Healthy Aging
|
N/A
|
N/A
|
May 29, 2023
|
Mar. 26–29, 2023
|
|
C1
|
Autophagy and Neurodegeneration: Mechanisms to Therapies
|
N/A
|
N/A
|
May 29, 2023
|
Mar. 26–29, 2023
|
|
D1
|
Myeloid Cells: Development, Diversity and Distinct Biological Roles
|
N/A
|
N/A
|
Jun 19, 2023
|
Apr. 16–19, 2023
|
|
D2
|
Innate Immunity: From Innate Sensing to Adaptive Responses
|
N/A
|
N/A
|
Jun 19, 2023
|
Apr. 16–19, 2023
|
|
X7
|
From First Breath: Lung Development, Infection, Repair and Aging
|
N/A
|
N/A
|
Jun 26, 2023
|
Apr. 23–26, 2023
|
|
X8
|
Inflammation in the Lung: Friend or Foe in Viral Infections?
|
N/A
|
N/A
|
Jun 26, 2023
|
Apr. 23–26, 2023
|
|
E1
|
Type 2 Diabetes: Understanding its Early Drivers and the Road to Therapeutics
|
N/A
|
N/A
|
Jul 4, 2023
|
May. 1–4, 2023
|
|
Z1
|
Metastasis
|
N/A
|
N/A
|
Jul 10, 2023
|
May. 7–10, 2023
|
|
Z2
|
The Resistant Tumor Microenvironment
|
N/A
|
N/A
|
Jul 10, 2023
|
May. 7–10, 2023
|
|
Z4
|
Neurodegeneration: New Biology Guiding the Next Generation of Therapeutic Development
|
N/A
|
N/A
|
Jul 19, 2023
|
May. 15–19, 2023
|
|
Z3
|
Neuroimmune Interactions: From Basic Mechanisms to Novel Therapeutic Directions
|
N/A
|
N/A
|
Jul 19, 2023
|
May. 15–19, 2023
|
|
E2
|
Hypoxia: From Basic Mechanisms to Emerging Therapies
|
N/A
|
N/A
|
Jul 31, 2023
|
May. 28–31, 2023
|
|
E3
|
New Frontiers in Reconstructing Human Evolution History
|
Feb 7, 2023
|
N/A
|
Aug 1, 2023
|
May. 29–Jun. 1, 2023
|
|
L2
|
Understanding Developmental Disorders in the Genomic Age
|
N/A
|
N/A
|
Aug 8, 2023
|
Jun. 6–8, 2023
|
|
Z5
|
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
|
Jan 31, 2023
|
May 29, 2023
|
Aug 10, 2023
|
Jun. 6–10, 2023
|
|
Z6
|
HIV Vaccines, Immunoprophylaxis and Drugs
|
Jan 31, 2023
|
May 29, 2023
|
Aug 10, 2023
|
Jun. 6–10, 2023
|
|
E4
|
Single Cell Biology: From Development to Cancer
|
N/A
|
N/A
|
Aug 22, 2023
|
Jun. 18–22, 2023
|
|
Z7
|
Heart Failure: All Cells Considered
|
N/A
|
N/A
|
Aug 28, 2023
|
Jun. 25–28, 2023
|
|
Z8
|
Pulmonary Hypertension: State of the Art and Therapeutic Opportunities
|
N/A
|
N/A
|
Aug 28, 2023
|
Jun. 25–28, 2023
|
|
F1
|
Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment
|
N/A
|
N/A
|
Oct 31, 2023
|
Aug. 27–30, 2023
|
|
F2
|
Transposable Elements at the Crossroads of Evolution, Health and Disease
|
N/A
|
N/A
|
Nov 7, 2023
|
Sep. 3–6, 2023
|
|
EK1
|
Next-Generation Nanomedicine
|
N/A
|
Aug 28, 2023
|
Nov 9, 2023
|
Sep. 6–8, 2023
|
|
F6
|
Vaccinology During and After COVID-19
|
May 16, 2023
|
Sep 10, 2023
|
Nov 21, 2023
|
Sep. 17–20, 2023
|
|
J2
|
T and B Cell Collaboration in Germinal Centers and Beyond
|
N/A
|
N/A
|
Dec 5, 2023
|
Oct. 1–4, 2023
|
|
J1
|
B Cells and Tertiary Lymphoid Structures: Emerging Targets in Cancer Therapeutics
|
N/A
|
N/A
|
Dec 5, 2023
|
Oct. 1–4, 2023
|
|
F3
|
Immunity and Aging
|
N/A
|
N/A
|
Dec 5, 2023
|
Oct. 1–4, 2023
|
|
G5
|
Cilia in Development and Disease
|
|
|
|
Oct. 1–4, 2023
|
|
H4
|
Vaccinology
|
|
|
|
Oct. 1–4, 2023
|
|
J3
|
Circulating Metabolic Intermediates as Fuels and Signals
|
N/A
|
N/A
|
Dec 12, 2023
|
Oct. 8–11, 2023
|
|
J4
|
Mechanisms of Microbiota-Immune Interactions-Towards the Next Decade
|
N/A
|
N/A
|
Dec 12, 2023
|
Oct. 8–11, 2023
|
|
F4
|
COVID-19 and the World Response: Are We Prepared for the Next Pandemic?
|
N/A
|
N/A
|
N/A
|
Nov. 12–16, 2023
|
|
J6
|
Ubiquitin Biology and Disease
|
N/A
|
N/A
|
Feb 7, 2024
|
Dec. 3–6, 2023
|
|
J5
|
Autophagy and Disease
|
N/A
|
N/A
|
Feb 7, 2024
|
Dec. 3–6, 2023
|
|
J7
|
RNA Modifications in Health and Disease
|
N/A
|
N/A
|
Feb 16, 2024
|
Dec. 12–15, 2023
|
|
J8
|
Regulatory RNAs: Emerging Mechanisms
|
N/A
|
N/A
|
Feb 16, 2024
|
Dec. 12–15, 2023
|
|
G8
|
Next-Generation Therapeutic Development in Inflammatory Bowel Disease
|
N/A
|
N/A
|
N/A
|
Jan. 1–4, 2024
|
|
H8
|
Neuropsychiatric and Neurodevelopmental Disorders: Harnessing Rare Variants
|
N/A
|
N/A
|
N/A
|
Jan. 1–4, 2024
|
|
W7
|
Eukaryotic Gene Regulation: New Mechanisms and Technologies
|
N/A
|
N/A
|
N/A
|
Jan. 1–4, 2024
|
|
Q2
|
Mammalian Somatosensation: Mechanisms of Itch, Touch, Pain and Interoception in Health and Disease
|
N/A
|
N/A
|
Mar 18, 2024
|
Jan. 14–17, 2024
|
|
Q1
|
Exercise Biology: Signaling, Mechanisms and Benefits
|
N/A
|
N/A
|
Mar 18, 2024
|
Jan. 14–17, 2024
|
|
A1
|
Inhibitory Receptors in Immune Homeostasis, Disease and Therapy
|
N/A
|
N/A
|
Mar 20, 2024
|
Jan. 16–19, 2024
|
|
Q4
|
Proximity Based Therapeutics
|
N/A
|
N/A
|
Mar 25, 2024
|
Jan. 21–24, 2024
|
|
A2
|
Single-Cell Biology: Tissue Genomics, Technologies and Disease
|
N/A
|
N/A
|
Mar 25, 2024
|
Jan. 21–24, 2024
|
|
Q3
|
Targeted Protein Degradation
|
N/A
|
N/A
|
Mar 25, 2024
|
Jan. 21–24, 2024
|
|
Q7
|
Delivery of Nucleic Acid Therapeutics
|
N/A
|
N/A
|
Mar 26, 2024
|
Jan. 22–25, 2024
|
|
Q5
|
Emerging Cellular Therapies
|
N/A
|
N/A
|
Mar 26, 2024
|
Jan. 22–25, 2024
|
|
Q8
|
Precision Genome Engineering
|
N/A
|
N/A
|
Mar 26, 2024
|
Jan. 22–25, 2024
|
|
Q6
|
Stem Cells and Regeneration
|
N/A
|
N/A
|
Mar 26, 2024
|
Jan. 22–25, 2024
|
|
A3
|
Myeloid Cell Diversity: From Fundamental Biology to Disease States
|
N/A
|
N/A
|
Apr 1, 2024
|
Jan. 28–31, 2024
|
|
2023 FALL
|
2023 Fall Study Group
|
|
|
|
Oct. 1–Jan. 31, 2024
|
|
X3
|
Cardiometabolic Diseases: The Role of Ethnic Diversity in Precision Medicine
|
N/A
|
N/A
|
Apr 8, 2024
|
Feb. 4–7, 2024
|
|
X4
|
Obesity Causes and Consequences
|
N/A
|
N/A
|
Apr 8, 2024
|
Feb. 4–7, 2024
|
|
B1
|
Epigenetic Mechanisms and Cancer Treatment
|
N/A
|
N/A
|
Apr 8, 2024
|
Feb. 4–7, 2024
|
|
T4
|
Stem Cell Models for Embryology
|
N/A
|
N/A
|
N/A
|
Feb. 6–8, 2024
|
|
B2
|
Systemic Autoimmune and Autoinflammatory Diseases
|
N/A
|
N/A
|
Apr 12, 2024
|
Feb. 8–11, 2024
|
|
T1
|
CANCELLED: Neurobiology of Reward and Addiction
|
N/A
|
N/A
|
N/A
|
Feb. 12–14, 2024
|
|
X6
|
Organelle Membrane Contact Sites in Health and Disease
|
N/A
|
N/A
|
Apr 16, 2024
|
Feb. 12–15, 2024
|
|
X5
|
Mitochondria Signaling and Disease
|
N/A
|
N/A
|
Apr 16, 2024
|
Feb. 12–15, 2024
|
|
B3
|
Tumor Metabolism
|
N/A
|
N/A
|
Apr 16, 2024
|
Feb. 12–15, 2024
|
|
X7
|
Fungal Pathogens: Emerging Threats and Future Challenges
|
N/A
|
N/A
|
Apr 22, 2024
|
Feb. 18–21, 2024
|
|
X8
|
Regulation of Barrier Immunity
|
N/A
|
N/A
|
Apr 22, 2024
|
Feb. 18–21, 2024
|
|
B4
|
Hematopoiesis
|
N/A
|
N/A
|
Apr 29, 2024
|
Feb. 25–28, 2024
|
|
C1
|
MASH and Fibrosis: From Molecular Phenotypes to Precision Therapeutics
|
N/A
|
N/A
|
May 7, 2024
|
Mar. 3–6, 2024
|
|
T2
|
Unraveling Vascular Layers to Understand Human Disease
|
N/A
|
N/A
|
N/A
|
Mar. 17–19, 2024
|
|
C2
|
Cancer Immunotherapy: Beyond Immune Checkpoint Blockade and Overcoming Resistance
|
N/A
|
N/A
|
May 21, 2024
|
Mar. 17–20, 2024
|
|
K2
|
Microbiota and Cancer Immunity
|
N/A
|
N/A
|
May 21, 2024
|
Mar. 17–20, 2024
|
|
C3
|
Immunometabolism: From Mechanisms to Pathways to Therapies
|
N/A
|
N/A
|
May 22, 2024
|
Mar. 18–21, 2024
|
|
C4
|
Tuberculosis: The Host-Pathogen Interface
|
Oct 24, 2023
|
Mar 13, 2024
|
May 28, 2024
|
Mar. 24–27, 2024
|
|
K1
|
HIV and (Re)Emerging Viruses: Aligning Lessons Across Pandemics
|
Nov 7, 2023
|
N/A
|
Jun 12, 2024
|
Apr. 8–11, 2024
|
|
Z2
|
Systems and Engineering Immunology: Advancing Immunological Insights in Health and Disease
|
N/A
|
N/A
|
Jun 13, 2024
|
Apr. 9–12, 2024
|
|
Z1
|
Innate Immunity Across the Molecular, Cellular, Tissue and Therapeutic
|
N/A
|
N/A
|
Jun 13, 2024
|
Apr. 9–12, 2024
|
|
C5
|
Cardiovascular Epigenetics and Gene Regulation
|
Dec 12, 2023
|
N/A
|
Jun 19, 2024
|
Apr. 15–18, 2024
|
|
EK2
|
AI in Biomedicine
|
N/A
|
Apr 22, 2024
|
Jul 4, 2024
|
May. 1–3, 2024
|
|
T3
|
Cachexia and Wasting Syndrome in Cancer and Chronic Diseases
|
N/A
|
N/A
|
N/A
|
May. 5–7, 2024
|
|
C6
|
Antibodies as Drugs: The Art in Antibody Engineering
|
N/A
|
N/A
|
Jul 9, 2024
|
May. 5–8, 2024
|
|
C7
|
Myeloid Targeting Strategies for Cancer Treatment
|
N/A
|
N/A
|
Jul 10, 2024
|
May. 6–9, 2024
|
|
Z3
|
Neurodegenerative Diseases
|
N/A
|
N/A
|
Aug 7, 2024
|
Jun. 3–6, 2024
|
|
Z4
|
Neuroimmune Interactions: Nervous System and Immune Cell Heterogeneity in Health and Disease
|
N/A
|
N/A
|
Aug 7, 2024
|
Jun. 3–6, 2024
|
|
F1
|
Biomolecular Condensates: Mechanisms and Therapeutic Opportunities
|
N/A
|
N/A
|
Nov 9, 2024
|
Sep. 6–9, 2024
|
|
T1
|
Targeting Dry Age-related Macular Degeneration: Pathophysiology and Emerging Therapies
|
N/A
|
N/A
|
Nov 20, 2024
|
Sep. 17–20, 2024
|
|
F2
|
Positive Strand RNA Viruses: Interdisciplinary Advances in Virology, Pathogenesis, Immunology, and Technology Development
|
N/A
|
N/A
|
Dec 24, 2024
|
Oct. 21–24, 2024
|
|
F3
|
MEETING CANCELED: GPCR Drug Discovery Meets Cell Mapping: A Keystone Integration Symposia
|
N/A
|
N/A
|
N/A
|
Oct. 27–30, 2024
|
|
F4
|
Fibrosis: Inflammation, Drivers, and Therapeutic Resolution
|
N/A
|
N/A
|
Feb 10, 2025
|
Dec. 8–11, 2024
|
|
G8
|
Delayed and Hidden Consequences of Infection
|
N/A
|
N/A
|
N/A
|
Jan. 1–4, 2025
|
|
A1
|
Precision Oncology: Emerging Technologies & Implementation
|
N/A
|
N/A
|
N/A
|
Jan. 12–15, 2025
|
|
A2
|
Mitochondrial Biology in Health and Disease
|
N/A
|
N/A
|
N/A
|
Jan. 13–16, 2025
|
|
J2
|
Neural Influence on Cancer, Tumor Microenvironment and Cancer Immunology
|
N/A
|
N/A
|
N/A
|
Jan. 18–21, 2025
|
|
J1
|
Tumor Microenvironment: Metastasis and the Host
|
N/A
|
N/A
|
N/A
|
Jan. 18–21, 2025
|
|
J3
|
Future of Agriculture for Sustainability
|
N/A
|
N/A
|
N/A
|
Jan. 20–23, 2025
|
|
J4
|
Genetic Engineering for a Sustainable Future
|
N/A
|
N/A
|
N/A
|
Jan. 20–23, 2025
|
|
J5
|
RNA Mediated Regulation of Immunity: Mechanism, Disease and Therapeutics
|
N/A
|
N/A
|
N/A
|
Jan. 27–30, 2025
|
|
J6
|
Non-Coding RNA Biology: New Roles and Diversity
|
N/A
|
N/A
|
N/A
|
Jan. 27–30, 2025
|
|
J7
|
T Cell Differentiation in Tissue Microenvironments
|
N/A
|
N/A
|
N/A
|
Feb. 2–5, 2025
|
|
J8
|
Innate Immune Memory: Mechanisms and Consequences
|
N/A
|
N/A
|
N/A
|
Feb. 2–5, 2025
|
|
T2
|
Microproteins: from Discovery to Applications
|
N/A
|
N/A
|
N/A
|
Feb. 6–8, 2025
|
|
Q1
|
Trajectories to Heart Failure: Immunometabolic Mechanisms
|
N/A
|
N/A
|
N/A
|
Feb. 10–13, 2025
|
|
Q2
|
Immunometabolism in Tissue Homeostasis and Diseases
|
N/A
|
N/A
|
N/A
|
Feb. 10–13, 2025
|
|
B1
|
Tuberculosis: Heterogeneity from Experimental Models to Human Disease
|
Sep 17, 2024
|
N/A
|
N/A
|
Feb. 16–19, 2025
|
|
B2
|
Proximity-Based Therapeutics: Targeted Protein Degradation and Other Pharmacological Approaches
|
N/A
|
N/A
|
N/A
|
Feb. 16–19, 2025
|
|
Q5
|
Somatic Mosaicism in Human Development, Aging, and Diseases
|
N/A
|
N/A
|
N/A
|
Feb. 17–20, 2025
|
|
Q6
|
Aging: New Frontiers in Rejuvenation and Gerotherapeutics
|
N/A
|
N/A
|
N/A
|
Feb. 17–20, 2025
|
|
Q4
|
Drug Delivery to the Brain: Emerging Modalities
|
N/A
|
N/A
|
N/A
|
Feb. 17–20, 2025
|
|
Q3
|
Antibodies as Drugs: Innovative Formats, Design and Engineering
|
N/A
|
N/A
|
N/A
|
Feb. 17–20, 2025
|
|
Q8
|
Host-Microbe Co-Evolution in Human Health: The Microbiome-Pathobiont Continuum
|
N/A
|
N/A
|
N/A
|
Feb. 18–21, 2025
|
|
Q7
|
Human Microbiome: Diversity, Selection and Adaptation
|
N/A
|
N/A
|
N/A
|
Feb. 18–21, 2025
|
|
X2
|
MASH Pathogenesis and Therapeutic Approaches
|
N/A
|
N/A
|
N/A
|
Feb. 23–26, 2025
|
|
X1
|
Obesity and Adipose Tissue
|
N/A
|
N/A
|
N/A
|
Feb. 23–26, 2025
|
|
B4
|
B Cells: Multifaceted Functions and Dysfunctions
|
N/A
|
N/A
|
N/A
|
Feb. 23–26, 2025
|
|
C2
|
Myeloid Cells: Roles in Different Tissue Microenvironments
|
Oct 9, 2024
|
N/A
|
N/A
|
Mar. 3–6, 2025
|
|
C1
|
Precision Genome Engineering: Translating the Human Genome to the Clinic
|
N/A
|
N/A
|
N/A
|
Mar. 3–6, 2025
|
|
X3
|
Cancer Immunotherapy: Clinical Lessons to New Modalities
|
N/A
|
N/A
|
N/A
|
Mar. 16–19, 2025
|
|
C3
|
Tumor Metabolism: Environmental Influences and Therapeutic Vulnerabilities
|
N/A
|
N/A
|
N/A
|
Mar. 16–19, 2025
|
|
X4
|
Immune Cell Therapies: Advances in Cancer and Autoimmune Disease
|
N/A
|
N/A
|
N/A
|
Mar. 16–19, 2025
|
|
X6
|
Imaging Biomolecules Across Scales: From Atoms to Tissues
|
N/A
|
N/A
|
N/A
|
Mar. 23–26, 2025
|
|
X5
|
Machine Learning Applied to Macromolecular Structure and Function
|
N/A
|
N/A
|
N/A
|
Mar. 23–26, 2025
|
|
X8
|
Interplay of Chromatin Architecture and Transcription Regulation
|
N/A
|
N/A
|
N/A
|
Mar. 30–Apr. 2, 2025
|
|
C4
|
Malaria: Mechanisms of Immunity & Protection
|
Oct 15, 2024
|
N/A
|
N/A
|
Mar. 30–Apr. 2, 2025
|
|
X7
|
Epigenetics in Development and Disease
|
N/A
|
N/A
|
N/A
|
Mar. 30–Apr. 2, 2025
|
|
D1
|
Lipids in Cellular Function and Disease
|
N/A
|
N/A
|
N/A
|
Apr. 6–9, 2025
|
|
D3
|
HIV Cure: Antiretroviral Therapy-Free Control of HIV Infection
|
Nov 5, 2024
|
N/A
|
N/A
|
Apr. 7–10, 2025
|
|
T3
|
Regenerative Biology of the Female Reproductive System
|
N/A
|
N/A
|
N/A
|
Apr. 10–12, 2025
|
|
T4
|
Interoception: Neural Sensing and Control of Organ Function
|
N/A
|
N/A
|
N/A
|
Apr. 22–24, 2025
|
|
D4
|
Neurobiology of Ingestive Behavior
|
N/A
|
N/A
|
N/A
|
Apr. 22–25, 2025
|
|
D5
|
DNA Replication Gaps, Cancer and Disease
|
N/A
|
N/A
|
N/A
|
Apr. 27–30, 2025
|
|
T5
|
Metabolic and Nutritional Control of Development and Cell Fate
|
N/A
|
N/A
|
N/A
|
May. 7–9, 2025
|
|
Z2
|
Organoids: Engineering Innovative Approaches for Basic and Translational Insight
|
N/A
|
N/A
|
N/A
|
May. 11–14, 2025
|
|
Z1
|
Single Cell Biology: Unique Cells to Tissue Ecosystems
|
N/A
|
N/A
|
N/A
|
May. 11–14, 2025
|
|
G1
|
Vaccinology: Horizons Across Disease, Demography and Technology
|
Jan 2, 2025
|
N/A
|
N/A
|
Jun. 4–7, 2025
|
|
Z3
|
Neural-Immune Interactions: A Systems-Wide Perspective on Whole Organism Physiology
|
N/A
|
N/A
|
N/A
|
Jun. 8–11, 2025
|
|
Z4
|
Neurodegeneration: Linking Cellular Pathways to Therapeutic Strategies
|
N/A
|
N/A
|
N/A
|
Jun. 8–11, 2025
|
|
E1
|
Climate Change & Infectious Disease Threats
|
Jan 28, 2025
|
N/A
|
N/A
|
Jun. 23–26, 2025
|
|
E2
|
Autophagosomes and Endolysosomes: From Fundamental Mechanisms to Disease Implications
|
N/A
|
N/A
|
N/A
|
Jun. 25–28, 2025
|
|
F1
|
Long COVID and Other Post-Acute Infection Syndromes
|
N/A
|
N/A
|
N/A
|
Aug. 10–13, 2025
|
|
G6
|
Computational Advances in Drug Discovery
|
N/A
|
N/A
|
N/A
|
Sep. 15–18, 2025
|
|
P8
|
AI in Molecular Biology
|
N/A
|
N/A
|
N/A
|
Sep. 15–18, 2025
|
|
F2
|
Predicting and Responding to Emerging Viral Infections
|
N/A
|
N/A
|
N/A
|
Oct. 13–16, 2025
|
|
R3
|
Plant Epigenetics and Epigenome Engineering
|
N/A
|
N/A
|
N/A
|
Jan. 1–4, 2026
|
|
G2
|
Autoimmunity & Autoinflammation: Translating Basic Mechanisms into Novel Therapeutic Approaches
|
N/A
|
N/A
|
N/A
|
Jan. 1–4, 2026
|
|
H3
|
Viral Pathogenesis and Immunity: From Molecular Discoveries to Therapeutics
|
N/A
|
N/A
|
N/A
|
Jan. 1–4, 2026
|
|
H7
|
Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk
|
N/A
|
N/A
|
N/A
|
Jan. 1–4, 2026
|
|
H8
|
Chronic Kidney Disease: Emerging Mechanisms, Consequences and Targeted Treatments
|
N/A
|
N/A
|
N/A
|
Jan. 1–4, 2026
|
|
G3
|
Solute Carrier Transporters: Structure, Physiology and Pharmacology
|
N/A
|
N/A
|
N/A
|
Jan. 1–4, 2026
|
|
G7
|
Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications & Combinations
|
N/A
|
N/A
|
N/A
|
Jan. 1–4, 2026
|
|
N4
|
Autophagy: Mechanisms to Therapy
|
N/A
|
N/A
|
N/A
|
Jan. 1–4, 2026
|
|
P1
|
Mitochondria Signaling in Physiology and Disease
|
N/A
|
N/A
|
N/A
|
Jan. 1–4, 2026
|
|
H9
|
Neurodevelopmental Disorders: Risk Factors and Molecular Mechanisms
|
|
|
|
Jan. 1–4, 2026
|
|
G9
|
Spotlight on the Cancer Cell: Intrinsic Properties and Vulnerabilities for Therapeutics
|
N/A
|
N/A
|
N/A
|
Jan. 1–4, 2026
|
|
N3
|
Membrane Dynamics, Repair and Disease
|
N/A
|
N/A
|
N/A
|
Jan. 1–4, 2026
|
|
P3
|
iPSCs: Progress, Opportunities, and Challenges
|
N/A
|
N/A
|
N/A
|
Jan. 1–4, 2026
|
|
P9
|
Epigenetics and Gene Regulation in Health and Disease: Linking Basic Mechanisms with Therapeutic Opportunities
|
N/A
|
N/A
|
N/A
|
Jan. 1–4, 2026
|
|
R1
|
RNA Modifications: Bridging Biological Function and Therapeutic Potential
|
N/A
|
N/A
|
N/A
|
Jan. 1–4, 2026
|
|
J2
|
Immunometabolism Across Scales: From Cells to Systems to Healthspan
|
N/A
|
N/A
|
N/A
|
Jan. 11–14, 2026
|
|
J1
|
From Systems Immunology to Immunoengineering
|
N/A
|
N/A
|
N/A
|
Jan. 11–14, 2026
|
|
H6
|
Fungal Pathogens: Emerging Threats and Future Challenges
|
N/A
|
N/A
|
N/A
|
Jan. 12–15, 2026
|
|
N1
|
Microbiome Metabolite/Metabolism Discovery and Function in Health and Disease: Bringing Biochemistry into the 21st Century
|
N/A
|
N/A
|
N/A
|
Jan. 19–22, 2026
|
|
N2
|
Human Microbiome: From Models and Mechanism to Medicine
|
N/A
|
N/A
|
N/A
|
Jan. 19–22, 2026
|
|
M6
|
Cardiometabolism in Health and Disease
|
N/A
|
N/A
|
N/A
|
Jan. 26–29, 2026
|
|
M5
|
Obesity Therapeutics: Unlocking Benefits and Minimizing Side Effects
|
N/A
|
N/A
|
N/A
|
Jan. 26–29, 2026
|
|
P6
|
Antibodies as Drugs: Engineering and Computational Tools Enabling Clinical Advances
|
N/A
|
N/A
|
N/A
|
Feb. 1–4, 2026
|
|
P7
|
Emerging Cell Therapies 2026
|
N/A
|
N/A
|
N/A
|
Feb. 1–4, 2026
|
|
L5
|
Fibrosis: Cross Organ Pathology and Pathways to Clinical Development
|
N/A
|
N/A
|
N/A
|
Feb. 2–5, 2026
|
|
L6
|
Stromal Immunology in Health and Disease
|
N/A
|
N/A
|
N/A
|
Feb. 2–5, 2026
|
|
P4
|
Stem Cell Models in Embryology
|
N/A
|
N/A
|
N/A
|
Feb. 17–19, 2026
|
|
G1
|
Myeloid Cells: Functional Heterogeneity with Therapeutic Promise
|
N/A
|
N/A
|
N/A
|
Feb. 23–26, 2026
|
|
G4
|
The Ubiquitin Family in Biology and Disease
|
N/A
|
N/A
|
N/A
|
Feb. 23–26, 2026
|
|
G5
|
Proximity Based Biology and Therapeutics: Targeted Protein Degradation and Beyond
|
N/A
|
N/A
|
N/A
|
Feb. 23–26, 2026
|
|
P2
|
Hematopoiesis
|
N/A
|
N/A
|
N/A
|
Feb. 23–26, 2026
|
|
N5
|
Precision Genome Engineering: From Basic Mechanisms to Application
|
N/A
|
N/A
|
N/A
|
Mar. 9–12, 2026
|
|
N6
|
Nucleic Acid Therapeutics and Targeted Delivery
|
N/A
|
N/A
|
N/A
|
Mar. 9–12, 2026
|
|
L3
|
B Cells and Plasma Cells: Fundamental and Translational Biology
|
N/A
|
N/A
|
N/A
|
Mar. 16–19, 2026
|
|
L4
|
B and T Cell Collaboration in Lymphoid and Nonlymphoid Microenvironments
|
N/A
|
N/A
|
N/A
|
Mar. 16–19, 2026
|
|
M7
|
Islet Biology and Diabetes: Beta Cell Compensation, Failure and Recovery
|
N/A
|
N/A
|
N/A
|
Mar. 16–19, 2026
|
|
M8
|
Gut-Brain Axis
|
N/A
|
N/A
|
N/A
|
Mar. 16–19, 2026
|
|
L7
|
Innate Immunity: Diversity in Host Defense and Disease
|
N/A
|
N/A
|
N/A
|
Mar. 22–25, 2026
|
|
L8
|
Aging: Immune Function and Organ Health
|
N/A
|
N/A
|
N/A
|
Mar. 22–25, 2026
|
|
H4
|
Tuberculosis: Understanding the Disease Across Scales
|
N/A
|
N/A
|
N/A
|
Mar. 23–26, 2026
|
|
R2
|
Global Cohort Studies: Closing the Diversity Gap in Genomics and Population Health
|
N/A
|
N/A
|
N/A
|
Apr. 27–30, 2026
|
|
H5
|
Beyond Antibiotics: Emerging Strategies for Combating Bacterial Infection
|
N/A
|
N/A
|
N/A
|
May. 4–7, 2026
|
|
P5
|
Immuno-Vaccinology: A New Era in Vaccine Design
|
N/A
|
N/A
|
N/A
|
May. 4–7, 2026
|
|
M2
|
Tumor Microenvironment: Identifying Drivers of Progression and Resistance
|
N/A
|
N/A
|
N/A
|
May. 17–20, 2026
|
|
M1
|
Inflammation Resolution: Emerging Concepts, Mechanisms and Disease Insights
|
N/A
|
N/A
|
N/A
|
May. 17–20, 2026
|
|
G8
|
Tumor Metabolism: New Frontiers in Diet, Microbiome and Beyond
|
N/A
|
N/A
|
N/A
|
Jun. 8–11, 2026
|
|
M4
|
HIV Vaccines: Intersections of Basic and Clinical Science
|
N/A
|
N/A
|
N/A
|
Jun. 15–18, 2026
|
|
M3
|
Decoding HIV Persistence: Strategies for Curing HIV Infection
|
N/A
|
N/A
|
N/A
|
Jun. 15–18, 2026
|
|
N7
|
Neurodegeneration: Neurocentric to System-Wide Perspectives
|
N/A
|
N/A
|
N/A
|
Jun. 22–25, 2026
|
|
N8
|
Neuroinflammation in Health and Disease
|
N/A
|
N/A
|
N/A
|
Jun. 22–25, 2026
|
